Arch Biopartners Inc
XTSX:ARCH

Watchlist Manager
Arch Biopartners Inc Logo
Arch Biopartners Inc
XTSX:ARCH
Watchlist
Price: 2.03 CAD 1.5%
Market Cap: 131.2m CAD
Have any thoughts about
Arch Biopartners Inc?
Write Note

Arch Biopartners Inc
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Arch Biopartners Inc
Income from Continuing Operations Peer Comparison

Comparables:
ABCL
RP
IOT

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
Arch Biopartners Inc
XTSX:ARCH
Income from Continuing Operations
-CA$6.1m
CAGR 3-Years
9%
CAGR 5-Years
-25%
CAGR 10-Years
-35%
Abcellera Biologics Inc
NASDAQ:ABCL
Income from Continuing Operations
-$146.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Replicel Life Sciences Inc
XTSX:RP
Income from Continuing Operations
-CA$69.3k
CAGR 3-Years
69%
CAGR 5-Years
51%
CAGR 10-Years
N/A
Innovotech Inc
XTSX:IOT
Income from Continuing Operations
-CA$364.5k
CAGR 3-Years
N/A
CAGR 5-Years
-116%
CAGR 10-Years
7%

See Also

What is Arch Biopartners Inc's Income from Continuing Operations?
Income from Continuing Operations
-6.1m CAD

Based on the financial report for Jun 30, 2024, Arch Biopartners Inc's Income from Continuing Operations amounts to -6.1m CAD.

What is Arch Biopartners Inc's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
-35%

Over the last year, the Income from Continuing Operations growth was -23%. The average annual Income from Continuing Operations growth rates for Arch Biopartners Inc have been 9% over the past three years , -25% over the past five years , and -35% over the past ten years .

Back to Top